Original Research

Published on 09 Apr 2024

Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Xiaojuan Zhang
Mina Zhang
Xinyang Du
Guowei Zhang
Yuanyuan Niu
Chunhua Wei
Lanwei Guo
Chao Shi
Hangfan Liu
Huijuan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1331138

1,977 views
4 citations

Original Research

Published on 08 Apr 2024

Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules

in Pharmacology of Anti-Cancer Drugs

Assem Barakat
Saeed Alshahrani
Abdullah Mohammed Al-Majid
Abdullah Saleh Alamary
Matti Haukka
Marwa M. Abu-Serie
Alexander Dömling
Luis R. Domingo
Yaseen A. M. M. Elshaier

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358089

1,193 views

Editorial

Published on 05 Apr 2024

Editorial: New mechanisms for anti-cancer drugs

in Pharmacology of Anti-Cancer Drugs

Ayaz Shahid
Ajit Prakash
Saad Mustafa
Pranav Kumar Prabhakar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387942

838 views

Original Research

Published on 05 Apr 2024

Decoding the research landscape of drug resistance and therapeutic approaches in head and neck cancer: a bibliometric analysis from 2000 to 2023

in Pharmacology of Anti-Cancer Drugs

Qi Han
Junqi Shi
Jiaojiao Liu
Yang Fu
Zhongxun Li
Huina Guo
Xiaoya Guan
Xuting Xue
Hongliang Liu
Liting Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375110

1,917 views

Original Research

Published on 05 Apr 2024

Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models

in Pharmacology of Anti-Cancer Drugs

Yun-Peng Huang
Yong-Xiang Wang
Hui Zhou
Zhong-Tao Liu
Zi-Jian Zhang
Li Xiong
Heng Zou
Yu Wen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1288255

1,708 views
2 citations

Original Research

Published on 03 Apr 2024

Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Jian Wang
Zhilong Zhang
Qian Li
Zilong Hu
Yuan Chen
Hao Chen
Wei Cai
Qiancheng Du
Peng Zhang
Dian Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1282361

2,437 views
1 citation

Mini Review

Published on 03 Apr 2024

Anticancer activities of natural abietic acid

in Pharmacology of Anti-Cancer Drugs

Bashir Ahmad
Chuan Tian
Ji-Xin Tang
John Sieh Dumbuya
Wen Li
Jun Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392203

2,993 views
6 citations

Review

Published on 26 Mar 2024

Phytocompounds targeting epigenetic modulations: an assessment in cancer

in Pharmacology of Anti-Cancer Drugs

Aqsa Khan
Asifa Khan
Mohammad Aasif Khan
Zoya Malik
Sheersh Massey
Rabea Parveen
Saad Mustafa
Anas Shamsi
Syed A. Husain

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1273993

2,709 views
3 citations

Review

Published on 26 Mar 2024

Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Min Sun
Jilei Sun
Wei Sun
Xiaonan Li
Zhe Wang
Liwei Sun
Yuehui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369352

1,943 views
5 citations

Original Research

Published on 25 Mar 2024

Paucatalinone A from Paulownia Catalpifolia Gong Tong Elicits mitochondrial-mediated cancer cell death to combat osteosarcoma

in Pharmacology of Anti-Cancer Drugs

Ganyu Wang
Zhiwei Cui
Jinqiu Tian
Xinyuan Li
Wenzhao Tang
Weiqiang Jing
Aiwu Li
Yuankai Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1367316

1,015 views

Systematic Review

Published on 22 Mar 2024

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Yan Wei
Li He
Tao Liu
Tao Guo
Cong Xie
Jigang Jia
Yonghong Lin
Jiang Liu
Jiayin Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372077

1,989 views
2 citations

Original Research

Published on 21 Mar 2024

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

in Pharmacology of Anti-Cancer Drugs

Aisha Shabir
Hina Qayoom
Burhan Ul Haq
Adel Abo Mansoor
Adil Abdelrahim
Irshad Ahmad
Abdullah Almilabairy
Fuzail Ahmad
Manzoor Ahmad Mir

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361424

1,635 views

Original Research

Published on 21 Mar 2024

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

in Pharmacology of Anti-Cancer Drugs

Run-Jie Wang
Rui-Quan Ke
Yi-Feng Yu
Guan-Zhong Lu
San-Gang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366853

956 views
1 citation

Original Research

Published on 21 Mar 2024

Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomerase

in Pharmacology of Anti-Cancer Drugs

Lijun Ma
Fangfang Ai
Hongyan Xiao
Fang Wang
Lei Shi
Xuehong Bai
Yongzhao Zhu
Wenping Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1367747

2,207 views
4 citations

Review

Published on 20 Mar 2024

Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma

in Pharmacology of Anti-Cancer Drugs

Chia-Hsien Shih
Yu-Hua Lin
Hao-Lun Luo
Wen-Wei Sung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1326296

2,372 views
4 citations

Original Research

Published on 19 Mar 2024

Identification of TBK1 inhibitors against breast cancer using a computational approach supported by machine learning

in Pharmacology of Anti-Cancer Drugs

Arif Jamal Siddiqui
Arshad Jamal
Mubashir Zafar
Sadaf Jahan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1342392

1,330 views
1 citation

Navigation group

Articles

Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer

Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules

Editorial: New mechanisms for anti-cancer drugs

Decoding the research landscape of drug resistance and therapeutic approaches in head and neck cancer: a bibliometric analysis from 2000 to 2023

Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models

Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma

Anticancer activities of natural abietic acid

Phytocompounds targeting epigenetic modulations: an assessment in cancer

Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential

Paucatalinone A from Paulownia Catalpifolia Gong Tong Elicits mitochondrial-mediated cancer cell death to combat osteosarcoma

Efficacy and safety of PARP inhibitors combined with antiangiogenic agents in the maintenance treatment of ovarian cancer: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomerase

Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma

Identification of TBK1 inhibitors against breast cancer using a computational approach supported by machine learning